The US Centers for Disease Control and Prevention (CDC) has endorsed recommendation that Novavax's Covid-19 vaccine be used as another primary series option for adults ages 18 years and older.
The recommendation came on Tuesday following a meeting of the CDC Advisory Committee on Immunization Practices, Xinhua news agency reported.
The Novavax vaccine will be available as two-dose primary series for adults, three weeks apart.
It is the fourth Covid-19 vaccine available in the US, and it uses a different type of vaccine technology than the other three approved vaccines.
"Novavax's Covid-19 vaccine, which will be available in the coming weeks, is an important tool in the pandemic and provides a more familiar type of Covid-19 vaccine technology for adults," said the CDC in a statement.
Last week, the US Food and Drug Administration issued an emergency use authorisation for the Novavax Covid-19 vaccine in individuals 18 years of age and older.
--IANS
int/shs
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app